Pimavanserin (Nuplazid): A Treatment for Hallucinations and Delusions Associated With Parkinson's Disease.

Article Details

Citation

Copy to clipboard

Cruz MP

Pimavanserin (Nuplazid): A Treatment for Hallucinations and Delusions Associated With Parkinson's Disease.

P T. 2017 Jun;42(6):368-371.

PubMed ID

28579723 [ View in PubMed

]

Abstract

Pimavanserin (Nuplazid) for the treatment of hallucinations and delusions associated with Parkinson's disease.

DrugBank Data that Cites this Article

Drugs

Pimavanserin

Drug Interactions

• Approved
• Vet approved
• Nutraceutical
• Illicit
• Withdrawn
• Investigational
• Experimental
• All Drugs

Drugs	Interaction
Integrate drug-drug interactions in your software
Pimavanserin Phenytoin	The metabolism of Pimavanserin can be increased when combined with Phenytoin.
Pimavanserin Fosphenytoin	The metabolism of Pimavanserin can be increased when combined with Fosphenytoin.
Pimavanserin Dexamethasone	The metabolism of Pimavanserin can be increased when combined with Dexamethasone.
Pimavanserin Pentobarbital	The metabolism of Pimavanserin can be increased when combined with Pentobarbital.
Pimavanserin Carbamazepine	The metabolism of Pimavanserin can be increased when combined with Carbamazepine.